As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI will co-organise a side event to explore the issue, addressing the various challenges and opportunities involved.
For decades, the United States has been a champion of the global drug control treaty system, which limits the use of marijuana exclusively to medical and scientific purposes, and obligates governments to punish and even criminalize recreational marijuana activity. But American attitudes toward marijuana policy are shifting: voters in Colorado and Washington approved ballot initiatives to legalize regulated recreational marijuana in 2012, and recent polls suggest that the majority of Americans think marijuana use should be legalized.
The ninth Latin America informal drug policy dialogue was devoted to "dilemmas in regulation of the cannabis market." The two-day dialogues were structured around seven sessions: (1) The Uruguayan proposal for cannabis regulation: dilemmas and challenges. (2) Current models of regulation: United States, Spain and the Netherlands. (3) The fine art of regulation: state monopoly vs. self-regulated market which works better and for whom? (4) Addressing cross-border differences and market mobility. (5) Tensions between cannabis regulation and international drug-control treaties: What options do governments have? (6) Cannabis reforms under way in Latin America. (7) Strategy and paths to reform: scenarios and next steps.